Margo Preminger Emont, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue, White | 4 | 2023 | 345 | 1.560 |
Why?
|
| Thermogenesis | 6 | 2022 | 429 | 1.270 |
Why?
|
| Adipocytes | 7 | 2021 | 1182 | 0.990 |
Why?
|
| Adipose Tissue | 6 | 2024 | 3278 | 0.880 |
Why?
|
| Atlases as Topic | 1 | 2022 | 237 | 0.750 |
Why?
|
| Adipose Tissue, Brown | 5 | 2022 | 754 | 0.540 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2015 | 32 | 0.520 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 657 | 0.520 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2015 | 202 | 0.480 |
Why?
|
| Subcutaneous Fat | 3 | 2018 | 391 | 0.470 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 302 | 0.450 |
Why?
|
| Intra-Abdominal Fat | 2 | 2021 | 591 | 0.400 |
Why?
|
| Insulin Resistance | 2 | 2022 | 3861 | 0.400 |
Why?
|
| Cell Culture Techniques | 2 | 2017 | 1670 | 0.390 |
Why?
|
| Hormones | 1 | 2015 | 884 | 0.380 |
Why?
|
| Hydrogels | 1 | 2015 | 723 | 0.360 |
Why?
|
| Dexamethasone | 2 | 2018 | 1949 | 0.330 |
Why?
|
| Stem Cells | 2 | 2023 | 3563 | 0.300 |
Why?
|
| Collagen | 1 | 2015 | 2684 | 0.290 |
Why?
|
| Adipocytes, Brown | 2 | 2018 | 144 | 0.290 |
Why?
|
| Receptors, Nicotinic | 2 | 2020 | 497 | 0.270 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 7721 | 0.250 |
Why?
|
| Cell Differentiation | 4 | 2021 | 11470 | 0.230 |
Why?
|
| Obesity | 8 | 2022 | 12705 | 0.230 |
Why?
|
| Adipocytes, White | 1 | 2023 | 89 | 0.210 |
Why?
|
| Cell Separation | 2 | 2018 | 1749 | 0.200 |
Why?
|
| RNA, Messenger | 1 | 2015 | 13029 | 0.180 |
Why?
|
| Acrolein | 1 | 2017 | 21 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 11695 | 0.160 |
Why?
|
| Thermography | 1 | 2018 | 67 | 0.150 |
Why?
|
| Mice | 14 | 2024 | 81045 | 0.150 |
Why?
|
| Luciferases | 2 | 2018 | 733 | 0.140 |
Why?
|
| Epithelium | 1 | 2021 | 1680 | 0.140 |
Why?
|
| Animals | 18 | 2024 | 168561 | 0.140 |
Why?
|
| Adiposity | 2 | 2022 | 1806 | 0.130 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2015 | 21 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2024 | 2968 | 0.130 |
Why?
|
| Receptor Cross-Talk | 1 | 2015 | 118 | 0.120 |
Why?
|
| Genes, Reporter | 2 | 2018 | 1547 | 0.120 |
Why?
|
| Signal Transduction | 4 | 2020 | 23387 | 0.120 |
Why?
|
| Lipolysis | 1 | 2015 | 211 | 0.120 |
Why?
|
| RNA | 1 | 2024 | 2747 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 729 | 0.110 |
Why?
|
| Epididymis | 1 | 2015 | 227 | 0.110 |
Why?
|
| Laminin | 1 | 2014 | 418 | 0.110 |
Why?
|
| Proteome | 1 | 2022 | 1790 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2017 | 1353 | 0.100 |
Why?
|
| Cell Communication | 1 | 2018 | 1619 | 0.100 |
Why?
|
| Protein Transport | 1 | 2015 | 1988 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3678 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2017 | 2017 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3862 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2015 | 5180 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2018 | 12164 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2015 | 4143 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2282 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 21821 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2017 | 5019 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2021 | 19223 | 0.060 |
Why?
|
| Gene Expression | 1 | 2015 | 7790 | 0.050 |
Why?
|
| Keratin-19 | 1 | 2021 | 33 | 0.050 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2022 | 123 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 9639 | 0.050 |
Why?
|
| Humans | 11 | 2024 | 742088 | 0.050 |
Why?
|
| WT1 Proteins | 1 | 2021 | 178 | 0.050 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2020 | 46 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5851 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2020 | 246 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2021 | 379 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2018 | 102 | 0.040 |
Why?
|
| Creatine | 1 | 2020 | 421 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2018 | 90 | 0.040 |
Why?
|
| Collagenases | 1 | 2018 | 228 | 0.040 |
Why?
|
| Flavoring Agents | 1 | 2017 | 48 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2017 | 112 | 0.040 |
Why?
|
| Smad3 Protein | 1 | 2017 | 180 | 0.040 |
Why?
|
| Acrylamides | 1 | 2018 | 252 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 12071 | 0.040 |
Why?
|
| Acetylcholine | 1 | 2018 | 621 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 2011 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 905 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 491 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2018 | 1683 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2017 | 358 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2024 | 5975 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2014 | 212 | 0.030 |
Why?
|
| Cell Size | 1 | 2014 | 643 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14554 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 2003 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 1737 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 4553 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6382 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 2006 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1887 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 3800 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15994 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2896 | 0.020 |
Why?
|
| Insulin | 1 | 2018 | 6575 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2014 | 3187 | 0.010 |
Why?
|
| Male | 2 | 2015 | 349538 | 0.010 |
Why?
|
| Aging | 1 | 2014 | 8626 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 56350 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 213712 | 0.000 |
Why?
|
| Female | 1 | 2018 | 379592 | 0.000 |
Why?
|